In accordance with the knockout data of CRISPR and RNAi in NSCLC cell lines, we assessed these candidate genes and identified seven pivotal markers, i.e., ACHE, CUTA, NGLY1, PTPRF, SYNCRIP, TAF13, and TIMM9. The gene discussed is ACHE; the disease is non-small cell lung carcinoma.